Dr. Michael F. Petroziello, MD

Dr. Petroziello practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. Petroziello's NPI, 1730345513, was assigned on July 31, 2008. Dr. Petroziello graduated from University at Buffalo School of Medicine in 2007. Dr. Petroziello holds New York license 269235.

Dr. Petroziello's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. Petroziello's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Petroziello is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Roswell Park Comprehensive Cancer Center. Dmand AI also links Dr. Petroziello to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Petroziello practices, 4 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Petroziello's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Petroziello is licensed in New York.

CMS data shows 421 Medicare services from Dr. Petroziello across 18 procedure codes in 2024, for 284 Medicare patients. Medicare paid $30,209 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 284 Medicare patients who saw Dr. Petroziello in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Petroziello's median patient age at 71, with 51% women.

In 2017, Dr. Petroziello wrote 70 Medicare Part D claims. Every claim was for a generic drug. They cover 3 drugs, with $584 in total drug cost. In 2016, CMS named 61 claims across 2 drugs.

Dr. Petroziello accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Petroziello, published from 2018 to 2023. 2021 was the busiest year, with 2. The most frequent topics are Kidney Neoplasms, Liver Neoplasms and Watchful Waiting. Dr. Petroziello's most frequent co-authors are Daniel B. Brown, MD, Jayson S. Brower, MD and Ripal Tarun Gandhi, MD.

CMS Open Payments shows 148 general payments to Dr. Petroziello from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. TriSalus Life Sciences, Inc. paid the most, $1,014.

Dr. Petroziello graduated from University at Buffalo School of Medicine in 2007.